Azole-echinocandin Combination Therapy for Invasive Aspergillosis
Condition(s):Invasive AspergillosisLast Updated:October 8, 2021Recruiting
Hide Studies Not Open or Pending
Condition(s):Invasive AspergillosisLast Updated:October 8, 2021Recruiting
Condition(s):Ventilator Associated Pneumonia; Respiratory Tract InfectionLast Updated:February 1, 2021Terminated
Condition(s):Invasive Candidiasis; CandidemiaLast Updated:September 22, 2011Unknown status
Condition(s):Invasive Candidiasis; Critically IllLast Updated:April 6, 2012Completed
Condition(s):Critically Ill PatientsLast Updated:August 5, 2019Unknown status
Condition(s):CandidemiaLast Updated:February 14, 2012Unknown status
Condition(s):Candidemia; Other Forms of Candida Infections(Intra-abdominal Abscess, Peritonitis)Last Updated:November 21, 2018Completed
Condition(s):Population Modeling of Anti-infective DrugsLast Updated:June 22, 2022Active, not recruiting
Condition(s):Candidiasis, Invasive; CandidemiaLast Updated:November 18, 2023Suspended
Condition(s):InfectionLast Updated:November 19, 2012Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.